TYM-3-98, a novel selective inhibitor of PI3Kδ, demonstrates promising preclinical antitumor activity in B-cell lymphomas

Autor: Lou, Si-yue, Zheng, Fan-li, Tang, Yong-mei, Zheng, Ya-nan, Lu, Jun, An, Hai, Zhang, En-jun, Cui, Sun-liang, Zhao, Hua-jun
Zdroj: In Life Sciences 15 June 2024 347
Databáze: ScienceDirect